1. Home
  2. ACHL vs BTCS Comparison

ACHL vs BTCS Comparison

Compare ACHL & BTCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHL
  • BTCS
  • Stock Information
  • Founded
  • ACHL 2016
  • BTCS 2008
  • Country
  • ACHL United Kingdom
  • BTCS United States
  • Employees
  • ACHL N/A
  • BTCS N/A
  • Industry
  • ACHL Biotechnology: Biological Products (No Diagnostic Substances)
  • BTCS Finance: Consumer Services
  • Sector
  • ACHL Health Care
  • BTCS Finance
  • Exchange
  • ACHL Nasdaq
  • BTCS Nasdaq
  • Market Cap
  • ACHL 46.8M
  • BTCS 50.9M
  • IPO Year
  • ACHL 2021
  • BTCS N/A
  • Fundamental
  • Price
  • ACHL $1.14
  • BTCS $3.57
  • Analyst Decision
  • ACHL Buy
  • BTCS Strong Buy
  • Analyst Count
  • ACHL 2
  • BTCS 1
  • Target Price
  • ACHL $4.00
  • BTCS $5.00
  • AVG Volume (30 Days)
  • ACHL 266.7K
  • BTCS 743.1K
  • Earning Date
  • ACHL 11-14-2024
  • BTCS 11-13-2024
  • Dividend Yield
  • ACHL N/A
  • BTCS N/A
  • EPS Growth
  • ACHL N/A
  • BTCS N/A
  • EPS
  • ACHL N/A
  • BTCS 0.24
  • Revenue
  • ACHL N/A
  • BTCS $2,077,859.00
  • Revenue This Year
  • ACHL N/A
  • BTCS $59.90
  • Revenue Next Year
  • ACHL N/A
  • BTCS $423.81
  • P/E Ratio
  • ACHL N/A
  • BTCS $14.57
  • Revenue Growth
  • ACHL N/A
  • BTCS 61.78
  • 52 Week Low
  • ACHL $0.63
  • BTCS $0.95
  • 52 Week High
  • ACHL $1.76
  • BTCS $5.41
  • Technical
  • Relative Strength Index (RSI)
  • ACHL 55.79
  • BTCS 63.47
  • Support Level
  • ACHL $1.12
  • BTCS $2.35
  • Resistance Level
  • ACHL $1.18
  • BTCS $2.58
  • Average True Range (ATR)
  • ACHL 0.05
  • BTCS 0.29
  • MACD
  • ACHL -0.00
  • BTCS 0.07
  • Stochastic Oscillator
  • ACHL 33.33
  • BTCS 68.16

About ACHL Achilles Therapeutics plc

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

About BTCS BTCS Inc.

BTCS Inc is engaged in the business of hosting an online e-commerce marketplace where consumers can purchase merchandise using Digital Assets, including bitcoin. The company focuses on blockchain and Digital Asset ecosystems. The firm operates a beta e-commerce marketplace, which accepts a range of digital currencies, has designed a beta secure digital currency storage solution BTCS Wallet.

Share on Social Networks: